Salt protein as a salt substitute
A novel salt protein developed via precision fermentation to serve as a healthier salt substitute, potentially reducing sodium intake in food products.
Overview
2D LLC is developing an innovative salt protein utilizing advanced precision fermentation techniques. This protein aims to serve as a healthier alternative to traditional salt, addressing the growing consumer demand for reduced sodium intake in food products. The use of engineered yeast strains to produce this protein represents a sustainable and potentially scalable solution for the food industry.
Technical specifications
The core technology involves the use of precision fermentation to produce proteins like Brazzein and Monellin, with the potential to incorporate Thaumatin sequences. These proteins are engineered using yeast strains optimized over two decades of research, allowing for the creation of a functional salt substitute. The development process capitalizes on the extensive experience in constructing over 500 peptide/protein sequences.
Technology readiness level
Currently, the salt protein is at Technology Readiness Level 2, indicating that the concept is formulated, and initial research has begun. The project is approaching the final stages of research, with an expected completion of the Brazzein yeast by March 2024. Subsequent steps include further development of combined yeast strains, regulatory preparation, and commercialization efforts once a buyer is identified.
About 2D LLC
CopX is a United States-based corporation focused on biotechnology and wellness products, including functional proteins, exosome preparations, and healthspan monitoring technologies. The company utilizes precision fermentation to produce proteins at scale, drawing on international research expertise to develop products aimed at supporting cellular function and mitigating age-related decline. Their portfolio includes 2D Functional Proteins, which are targeted blends designed to replenish essential peptides, and 2D Exomax, an exosome preparation derived from human umbilical cord mesenchymal stem cells for regenerative science applications. The company also promotes the 2DHeal network, which integrates health assessments such as AI-powered retinal imaging—using Airdoc camera technology—with their product offerings to provide personalized wellness insights.
By leveraging advanced manufacturing and diagnostic tools, CopX aims to support professional and research applications in health and integrative medicine. The company maintains international operational facilities for manufacturing and research, emphasizing scalability and sustainable production methods. Their model involves providing high-quality biological materials and screening services to health professionals and partners worldwide, focusing on addressing chronic inflammatory and degenerative health challenges. Through strategic collaborations and a emphasis on continuous production, CopX seeks to facilitate advancements in areas ranging from alternative proteins to biopharmaceuticals and personalized anti-aging protocols.
Inquire about this partnering listing
Industry applications
delivered to your inbox.